University of California San Francisco
Displaying 10231 - 10260 of 16515
-
-
Tears of Triumph at Arthritis Foundation Benefit
-
Health: Marijuana Goes Mainstream
-
Low Level HIV in Bloodstream Not Linked With Inflammation or Death
Low level HIV viremia – the presence of HIV in the bloodstream at levels undetectable by standard tests – was not associated with increased blood markers of inflammation or coagulation, or with increased risk of death, in adults taking highly active anti-retroviral therapy (HAART) for HIV infection, in a study led by researchers at the San Francisco VA Medical Center and UCSF.
-
'Cyborg' Yeast Genes Run by Computer
-
Aptos Man Donates Kidney, and Gives Cousin Second Shot at Life
-
UCSF Gets American Heart Association Award as Fit-Friendly Employer
<p>UCSF was recently recognized as a 2011 gold-level recipient of the American Heart Association’s Start! Fit-Friendly Companies Recognition program. </p>
-
Nursing Home Residents Face Greater Surgery Risks
-
Bay Area Hospitals Struggling with Drug Shortages
-
Rewriting the Textbook on Disease
-
UCSF Aims to Become Workplace of Choice
<p>Since reviewing the results of the 2011 employee engagement survey, UCSF has been working to ensure everyone knows exactly what is expected of them and to foster an environment where everyone can thrive.</p>
-
UCSF Mission Bay Med Center Helps DPR Thrive
-
Headache Tree Is a Pain in the Brain
-
HealthWatch: What's in the Paleo Diet?
-
FDA-Approved Drug Might Prevent Relapse in Male Alcoholics
Mifepristone, a drug approved by the U.S. Food and Drug Administration for terminating early pregnancy, might prove effective in preventing stress-induced relapse in recovering male alcoholics, based on findings in rats reported by researchers at the Ernest Gallo Clinic and Research Center at UCSF.
-
'Startling' Study Could Change How Doctors Treat Prostate Cancer
-
Gladstone Scientists Identify Gene Critical for Cell Responses to Oxygen Deprivation
Scientists at the UCSF-affiliated Gladstone Institutes have identified a protein that kick–starts the response to low levels of oxygen, suggesting new lines of research relevant to a variety of potentially fatal disorders associated with diminished oxygen supply, including cancer, heart disease, stroke and other neurological conditions that affect millions of people worldwide.
-
UCSF Training Program Attracts Best Minds in Developmental, Stem Cell Biology
<p>UCSF's pioneering program in Development and Stem Cell Biology attracts the nation's best faculty and students who are interested in understanding how embryos develop and how cells make tissues and organs – information needed to design novel therapies to cure diseases and treat injuries.</p>
-
Cancer Rate Doubled for Transplant Patients
-
Panel Calls for Google Maps of Human Disease
-
Duke Leads $25M Collaborative Project to Sequence 4,000 Genomes for Epilepsy Research
-
U.S. Glossed Over Cancer Concerns Associated with Airport X-Ray Scanners
-
Reassuring Study on Breast Cancer Genetic Mutation
-
Johnson & Johnson Baby Shampoo Has Cancer-Causing Chemicals, Group Says
-
Life Span Is a Moving Target
-
Sleep Disorders and Dementia Linked
-
Asthmatic Kids at Risk in the Central Valley
-
UC to Standardize Human Resources, Payroll Processes Across Campuses
<p>The University of California has begun work to deploy an integrated payroll and human resource system across all 10 campuses and five medical centers to streamline business operations and save money.</p>
-
UCSF Consortium Collaborates to Invent Medical Devices for Children
<p>The UCSF “D’Vice Squad,” a group of innovators from across the Bay Area, has drawn from diverse disciplines over the last two years to develop medical devices for children. </p>
-
New Drug Shows Promise Against Multiple Sclerosis
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.